INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $13,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 697,763 | $27,010,000 | 4.43% |
| Tamarack Capital Management, LLC | 235,000 | $9,097,000 | 2.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 196,117 | $7,591,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 132,862 | $6,093,000 | 0.36% |
| EMERALD ADVISERS, LLC | 118,242 | $4,577,000 | 0.25% |
| PDT Partners, LLC | 30,038 | $1,163,000 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 96,334 | $3,729,000 | 0.14% |
| Convergence Investment Partners, LLC | 17,450 | $675,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 122,556 | $4,744,000 | 0.11% |
| Spark Investment Management LLC | 13,992 | $541,000 | 0.09% |